|
TYPE OF TEST: TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE: Subcutaneous
SPECIES OBSERVED: Rodent - rat
DOSE: 12500 ug/kg
SEX DURATION: female 16-20 day(s) after conception
TOXIC EFFECTS:
Reproductive - Effects on Newborn - stillbirth
REFERENCE:
PSEBAA Proceedings of the Society for Experimental Biology and Medicine.
(Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04-
Volume(issue)/page/year: 94,746,1957
TYPE OF TEST: TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE: Subcutaneous
SPECIES OBSERVED: Rodent - rat
DOSE: 12500 ug/kg
SEX DURATION: female 16-20 day(s) after conception
TOXIC EFFECTS:
Reproductive - Effects on Newborn - stillbirth
REFERENCE:
PSEBAA Proceedings of the Society for Experimental Biology and Medicine.
(Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04-
Volume(issue)/page/year: 94,746,1957
TYPE OF TEST: TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE: Subcutaneous
SPECIES OBSERVED: Rodent - rat
DOSE: 12500 ug/kg
SEX DURATION: female 16-20 day(s) after conception
TOXIC EFFECTS:
Reproductive - Effects on Newborn - stillbirth
REFERENCE:
PSEBAA Proceedings of the Society for Experimental Biology and Medicine.
(Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04-
Volume(issue)/page/year: 94,746,1957
TYPE OF TEST: TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE: Subcutaneous
SPECIES OBSERVED: Rodent - rat
DOSE: 12500 ug/kg
SEX DURATION: female 16-20 day(s) after conception
TOXIC EFFECTS:
Reproductive - Effects on Newborn - stillbirth
REFERENCE:
PSEBAA Proceedings of the Society for Experimental Biology and Medicine.
(Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04-
Volume(issue)/page/year: 94,746,1957
TYPE OF TEST: TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE: Subcutaneous
SPECIES OBSERVED: Rodent - rat
DOSE: 12500 ug/kg
SEX DURATION: female 16-20 day(s) after conception
TOXIC EFFECTS:
Reproductive - Effects on Newborn - stillbirth
REFERENCE:
PSEBAA Proceedings of the Society for Experimental Biology and Medicine.
(Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04-
Volume(issue)/page/year: 94,746,1957
TYPE OF TEST: TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE: Subcutaneous
SPECIES OBSERVED: Rodent - rat
DOSE: 12500 ug/kg
SEX DURATION: female 16-20 day(s) after conception
TOXIC EFFECTS:
Reproductive - Effects on Newborn - stillbirth
REFERENCE:
PSEBAA Proceedings of the Society for Experimental Biology and Medicine.
(Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04-
Volume(issue)/page/year: 94,746,1957
TYPE OF TEST: TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE: Subcutaneous
SPECIES OBSERVED: Rodent - rat
DOSE: 12500 ug/kg
SEX DURATION: female 16-20 day(s) after conception
TOXIC EFFECTS:
Reproductive - Effects on Newborn - stillbirth
REFERENCE:
PSEBAA Proceedings of the Society for Experimental Biology and Medicine.
(Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04-
Volume(issue)/page/year: 94,746,1957
TYPE OF TEST: TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE: Subcutaneous
SPECIES OBSERVED: Rodent - rat
DOSE: 12500 ug/kg
SEX DURATION: female 16-20 day(s) after conception
TOXIC EFFECTS:
Reproductive - Effects on Newborn - stillbirth
REFERENCE:
PSEBAA Proceedings of the Society for Experimental Biology and Medicine.
(Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1903/04-
Volume(issue)/page/year: 94,746,1957
TYPE OF TEST: Unscheduled DNA synthesis
ROUTE OF EXPOSURE: Subcutaneous
TEST SYSTEM: Rodent - rat
DOSE DURATION: 40 mg/kg
REFERENCE:
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
36,2223,1976
TYPE OF TEST: Unscheduled DNA synthesis
TEST SYSTEM: Rodent - rat
DOSE DURATION: 40 mg/kg
REFERENCE:
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
36,2223,1976
TYPE OF TEST: Unscheduled DNA synthesis
ROUTE OF EXPOSURE: Subcutaneous
TEST SYSTEM: Rodent - rat
DOSE DURATION: 40 mg/kg
REFERENCE:
CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
Sts., Philadelphia, PA 19106) V.1- 1941- Volume(issue)/page/year:
36,2223,1976
|
|
|
| CHEMICAL GROUP
|
| NAME | CAS | SYSNONYMS |
| Prevocel #12 | 81296-82-4 | |
| Prevotsel NG-12 | | |
| Prevotsel wofp-100-NF | | |
| Primary aliphatic (C10-C16) amines | | |
| Primary fatty (C10-C13) alcohols | | |
| Primene JM-T | 68955-54-4 |
* Amines, C16-22-tert-alkyl68955-54-4
EINECS 273-280-7
Primene JM-T
t-Alkyl(C16-C22) primary amines
|
| PP 554 | |
* Czech experimental compound PP 554 |
| Primene 81-R | 68955-53-3 |
* Amines, C12-14-tert-alkyl68955-53-3
EINECS 273-279-1
Primene 81-R
t-Alkyl (C12-C14) primary amines
|
| Primex | 8041-44-9 | 8041-44-9
Primex
|
| Primula denticulata Sm., extract | |
* Bishkopra, extract |
| Primula floribunda Wall., extract | | |
| Primula petiolaris Wall., extract | | |
| Primulic acid | 53078-36-7 |
* Primulasaure4-18-00-05150 (Beilstein Handbook Reference)
53078-36-7
BRN 0078553
NSC 409073
Primulasaure [German]
Primulic acid
beta-D-Galactopyranosiduronic acid, (3beta,16alpha)-16,28-dihydroxyolean-12-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-(O-beta-D-glucopyranosyl-(1-6)-beta-D-galactopyranosyl-(1- 4))- (9CI)
.beta.-D-Galactopyranosiduronic acid, (3.beta.,16.alpha.)-16,28-dihydroxyolean-12-en-3-yl O-6-deoxy-.alpha.-L-mannopyranosyl-(1.fwdarw.2)-O-[O-.beta.-D-glucopyranosyl-(1.fwdarw.6)-.beta.-D-galactopyranosyl-(1.fwdarw.4)]-
NSC409073
PRIMULIC ACID
|
| Primuline, sodium salt | 8064-60-6 |
* C.I. Direct Yellow 7, sodium salt
* Thioflavine S8064-60-6
C.I. 49000
C.I. Direct Yellow 59
NSC72275
Primuline
Primuline, sodium salt
Primulinesulfonic acid
[2,6':2',6''-Terbenzothiazole]-7-sulfonic acid, 2''-(4-aminophenyl)-6-methyl-, monosodium salt, mixt. with 2'-(4-aminophenyl)-6-methyl[2,6'-bibenzothiazole]-7-sulfonic acid monosodium salt
(2,6'-:2',6''-Terbenzothiazole)-7-sulfonic acid, 2''-(4-aminophenyl)-6-methyl-, monosodium salt, mixture with 2'-(4-aminophenyl)-6-methyl(2,6'-benzothiazole)-7-sulfonic acid, monosodium salt
(2,6':2',6''-Terbenzothiazole)-7-sulfonic acid, 2''-(4-aminophenyl)-6-methyl-, monosodium salt, mixt. with 2'-(4-aminophenyl)-6-methyl(2,6-bibenzothiazole)-7-sulfonic acid monosodium salt
NSC 72275
PRIMULIN
PRIMULINE
|
| Primycin, sulfate | 30003-49-7 |
* Debrycin sulfate
* Ebrimycin
* Primycin A(sub 1) sulfate |
Primycin A(sub 1),
1,35-deepoxy-37-deoxy-1,37-epoxy-35-hydroxy-,
monoacetate (salt) | 128644-53-1 |
* 1,35-Deepoxy-37-deoxy-1,37-epoxy-35-hydroxyprimycin A(sub 1) monoacetate
(salt)
* Pseudo-primycin A(sub 1) acetate1,35-Deepoxy-37-deoxy-1,37-epoxy-35-hydroxyprimycin A(sub 1) monoacetate (salt)
128644-53-1
Primycin A(sub 1), 1,35-deepoxy-37-deoxy-1,37-epoxy-35-hydroxy-, monoacetate (salt)
|
| Prinsepia utilis Royle, extract | | |
| Practomycin C | 52810-78-3 | 52810-78-3
Practomycin C
|
| Printing processes | | |
| Priva cordifolia (L.f.) Druce, extract | |
* Priva leptostachya Juss., extract |
| Proactinomycin A | 1404-33-7 | 1404-33-7
Proactinomycin A
|
| Proactinomycin B | 1404-34-8 | 1404-34-8
Proactinomycin B
|
| Proactinomycin C | 1404-35-9 | 1404-35-9
Proactinomycin C
|
| Proceomycin | 11006-50-1 | 11006-50-1
Proceomycin
|
| Proceroside | 25323-74-4 |
* Proceroside (Calotropis)25323-74-4
|
| Prodeco prodesolv 128 D | | |
| Prodigiozan | 9057-00-5 |
* Prodigiosan9057-00-5
Prodigiozan
|
| Proflamin | 96231-73-1 | 96231-73-1
Proflamin
|
| Pramitol 5PS | | |
| Progesterone | 57-83-0 |
* Agolutin
* Bio-luton
* Corlutin
* Corlutina
* Corluvite
* Corporin
* Corpus luteum hormone
* delta(sup 4)-Pregnene-3,20-dione
* Flavolutan
* Fologenon
* Gesterol 100
* Gestone
* Gestormone
* Glanducorpin
* Gynlutin
* Gynoluton
* Hormoflaveine
* Hormoluton
* Lingusorbs
* Lipo-lutin
* Lucorteum Sol
* Luteal hormone
* Luteinique
* Luteodyn
* Luteogan
* Luteohormone
* Luteol
* Luteosan
* Luteostab
* Luteovis
* Lutex
* Lutidon
* Lutocyclin
* Lutocyclin M
* Lutocylin
* Lutoform
* Lutogyl
* Lutren
* Lutromone
* Nalutron
* NSC-9704
* Percutacrine Luteinique
* Piaponon
* Pregn-4-ene-3,20-dione
* 4-Pregnene-3,20-dione
* Primolut
* Progekan
* Progestasert
* Progesterol
* beta-Progesterone
* Progesteronum
* Progestin
* Progestone
* Prolidon
* Prolutone
* Syngesterone
* Syngestrets
* Synovex S
* Syntolutan.beta.-Progesterone
.delta.(sup4)-Pregnene-3,20-dione
.delta.4-Pregnene-3,20-dione
17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione
17.alpha.-Progesterone
3,20-Pregnene-4
57-83-0
6.alpha.-Methylpregn-4-en-17.alpha.-ol-3,20-dione
Colprosterone
Cyclogest
Gestron
Gynolutone
Lipo-Lutin
Luteine
Luteocrin normale
Luteopur
Lutociclina
Lutocylol
MPA
Membrettes
Methylpregnone
NSC9704
Pranone
Pregn-4-ene-3,20-dione, 17.alpha.-hydroxy-6.alpha.-methyl-
Pregnenedione
Progestosol
Progestron
Progestronol
Prolets
Prolutin
Protormone
Utrogestan
WLN: L E5 B666 OV MUTJ A1 E1 FV1
component of Cyclogesterin
NSC64377
AIDS-070516
AIDS070516
Lipolutin
17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione
17alpha-Progesterone
6alpha-Methylpregn-4-en-17alpha-ol-3,20-dione
AI3-51682
CCRIS 533
CMC_13406
Crinone
Crinone progesterone gel
D4-Pregnene-3,20-dione
Gesterol 50
Gestiron
HSDB 3389
Lugesteron
Luteal Hormone
Luteol (VAN)
Luteum
Lutocuclin M
Pregn-4-ene-3,20-dione, 17alpha-hydroxy-6alpha-methyl-
Prochieve
Progeffik
Progestogel
Progestol
Projestaject
Prometrium
Prontogest
U 3672
Vitarrine
delta(sup4)-Pregnene-3,20-dione
Crinone (TN)
D00066
Progesterone (JP15/USP/INN)
Prometrium (TN)
Prestwick_411
NCGC00090798-01
NCGC00090798-02
PREGANE-3,20-DIONE
D011374
Progesterone, (13 alpha,17 alpha)-(+-)-Isomer
Progesterone, (17 alpha)-Isomer
Progesterone, (9 beta,10 alpha)-Isomer
Delta4 -Pregnen-3,20-dione
PROGESTERONE
|
Progesterone, dihydroxy-, acetophenide mixed with
estradiol enanthate (15:1) | |
* DPA and estradiol enanthate (15:1) |
| Prolactin | 9002-62-4 |
* Adenohypophyseal luteotropin
* Anterior pituitary luteotropin
* Bovine lactogenic hormone
* Bovine prolactin
* Galctin
* Lactogen
* Lactogenic hormone
* Lactosomatotropic hormone
* Luteotrophin
* Luteotropic hormone
* Luteotropic Hormone LTH
* Luteotropin
* Mammotropin
* Ovine prolactin
* Paralctin
* Pituitary lactogenic hormone9002-62-4
Galactin
Lactogen, pituitary
Lactogenic hormone, pituitary
Lactogenic pituitary hormones
Luteotropic hormone LTH
NSC25935
Panlitar
Paralactin
Pituitary gland, lactogenic hormone
Pituitary hormones, lactogenic
Prolactin (8CI 9CI)
CCRIS 704
Gonadotropin, prolactin
Gonadotropin,luteotropic hormone
Lactin
Lactogenic hormone (VAN)
Lactosomatotropic hormone (VAN)
Lactosomatotropin
NSC 25935
Prolactin, human
|
L-Prolinamide,
N-((1-(2-aminoethyl)hexahydro-2,6-dioxo-4-pyrimidinyl
)carbonyl)-L-histidyl -, (RS)-, dihydrate | | |
L-Prolinamide,
N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-N-methy
l-D-phenylalanyl-, (S)-, sulfate (1:1) | 126721-07-1 | 105806-65-3 (Parent)
126721-07-1
L-Prolinamide, N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-N-methyl-D-phenylalanyl-, (S)-, sulfate (1:1)
L-Prolinamide, N-methyl-D-phenylalanyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-, (S)-, sulfate (1:1)
UNII-VB4VCH77JV
D03722
Efegatran sulfate
Efegatran sulfate (USAN)
|
L-Prolinamide,
N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-D-pheny
lalanyl-, sulfate, (S)- | 83997-16-4 |
* GYKI 14166
* (S)-D-Phenylalanyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-L-proli
namide sulfate (1:1)
* D-Phenylalanyl-L-prolyl-L-arginine aldehyde sulfate (1:1)
* RGH-2958(S)-D-Phenylalanyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-L-prolinamide sulfate (1:1)
83997-16-4
L-Prolinamide, N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-D-phenylalanyl-, sulfate, (S)-
|
L-Prolinamide,
N-(4-((aminoiminomethyl)amino)-1-cyanobutyl)-D-phenyl
alanyl-, (S)- | 111009-86-0 |
* (S)-N-(4-((Aminoiminomethyl)amino)-1-cyanobutyl)-D-phenylalanyl-L-prolin
amide
* D-Phenylalanyl-L-prolyl-L-arginine nitrile(S)-N-(4-((Aminoiminomethyl)amino)-1-cyanobutyl)-D-phenylalanyl-L-prolinamide
111009-86-0
L-Prolinamide, D-phenylalanyl-N-(4-((aminoiminomethyl)amino)-1-cyanobutyl)-, (S)-
L-Prolinamide, N-(4-((aminoiminomethyl)amino)-1-cyanobutyl)-D-phenylalanyl-, (S)-
Phenylalanyl-prolyl-arginine nitrile
|
L-Prolinamide,
N-((1-(carboxymethyl)hexahydro-2,6-dioxo-4-pyrimidiny
l)carbonyl)-L-histidy l-, (S)-, hydrate (2:3) | 128056-14-4 | 128056-14-4
L-Prolinamide, N-((1-(carboxymethyl)hexahydro-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate (2:3)
|
L-Prolinamide,
N-((2-(10,11,17,18,23,24,25,26,27,28-decahydro-14-met
hyl-11-(2-(methylamin
o)-2-oxoethyl)-18,28-bis(1-methylethyl)-9,16,23,26-te
traoxo-9H,16H-8,5:15, 12:22,19:32,29:36,33-
pentanitrilo-5H,29H,33H-pyrido(3,2-a1)(1,11,18,25,31,
4,7,14,21)pentathiate traazacyclotetratri
acontin-2-yl)-4-thiazolyl)carbonyl)-L-seryl- | 156620-48-3 |
* Amythiamicin B156620-48-3
L-Prolinamide, N-((2-(10,11,17,18,23,24,25,26,27,28-decahydro-14-methyl-11-(2-(methylamino)-2-oxoethyl)-18,28-bis(1-methylethyl)-9,16,23,26-tetraoxo-9H,16H-8,5:15,12:22,19:32,29:36,33-pentanitrilo-5H,29H,33H-pyrido(3,2-a1)(1,11,18,25,31,4,7,14,21)pentathiatetraazacyclotetratriacontin-2-yl)-4-thiazolyl)carbonyl)-L-seryl-
|
L-Prolinamide,
N-((1,1-dimethylethoxy)carbonyl)-D-phenylalanyl-N-(4-
((aminoiminomethyl) amino)-1-formylbutyl)-, (S)-,
sulfate (2:1) | 83861-29-4 |
* GYKI-1445183861-29-4
L-Prolinamide, N-((1,1-dimethylethoxy)carbonyl)-D-phenylalanyl-N-(4-((aminoiminomethyl)amino)-1-formylbutyl)-, (S)-, sulfate (2:1)
|
| Praseodymium chloride | 10361-79-2 | 10361-79-2
NSC84276
Praseodymium chloride
Praseodymium chloride (PrCl3)
Praseodymium chloride, PrCl3
Praseodymium trichloride
Praseodymium(III) chloride
WLN: PR G3
EINECS 233-794-4
NSC 84276
|
L-Prolinamide,
N,N-dimethyl-L-phenylalanyl-N-(5,8-dioxo-3-phenyl-7-(
phenylmethyl)-2-oxa-6 ,9-
diazabicyclo(10.2.2)hexadeca-10,12,14,15-tetraen-4-yl
)-, (3R-(3R*,4S*,7S*))-, sulfamate | 19542-40-6 |
* Adouetine Z amidosulfonate19542-40-6
Adouetine Z amidosulfonate [French]
L-Prolinamide, N,N-dimethyl-L-phenylalanyl-N-(5,8-dioxo-3-phenyl-7-(phenylmethyl)-2-oxa-6,9-diazabicyclo(10.2.2)hexadeca-10,12,14,15-tetraen-4-yl)-, (3R-(3R*,4S*,7S*))-, sulfamate
|
L-Prolinamide,
N-((1-(2-fluoroethyl)hexahydro-2,6-dioxo-4-pyrimidiny
l)carbonyl)-L-histidy l-, (S)-, hydrate | 128056-05-3 | 128056-05-3
L-Prolinamide, N-((1-(2-fluoroethyl)hexahydro-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate
|
L-Prolinamide,
N-((hexahydro-1-butyl-2,6-dioxo-4-pyrimidinyl)carbony
l)-L-histidyl-, hydrate | 128056-06-4 |
* N-((Hexahydro-1-butyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-L-pro
linamide hydrate128056-06-4
L-Prolinamide, N-((hexahydro-1-butyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, hydrate
N-((Hexahydro-1-butyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-L-prolinamide hydrate
|
L-Prolinamide,
N-((hexahydro-1-butyl-3-methyl-2,6-dioxo-4-pyrimidiny
l)carbonyl)-L-histidy l-, (RS)-, hydrate | | |
L-Prolinamide,
N-((hexahydro-1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)ca
rbonyl)-L-histidyl-, (S)-, hemihydrate | 128056-17-7 | 128056-17-7
L-Prolinamide, N-((hexahydro-1,3-dimethyl-2,6-dioxo-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hemihydrate
|
L-Prolinamide,
N-((hexahydro-2,6-dioxo-1-pentyl-4-pyrimidinyl)carbon
yl)-L-histidyl-, hydrate | 128083-59-0 |
* N-((Hexahydro-2,6-dioxo-1-pentyl-4-pyrimidinyl)carbonyl)-L-histidyl-L-pr
olinamide hydrate128083-59-0
L-Prolinamide, N-((hexahydro-2,6-dioxo-1-pentyl-4-pyrimidinyl)carbonyl)-L-histidyl-, hydrate
N-((Hexahydro-2,6-dioxo-1-pentyl-4-pyrimidinyl)carbonyl)-L-histidyl-L-prolinamide hydrate
|
L-Prolinamide,
N-((hexahydro-2,6-dioxo-1-(2-(phenylmethoxy)ethyl)-4-
pyrimidinyl)carbonyl) -L- histidyl-, (RS)- | | |
L-Prolinamide,
N-((hexahydro-2,6-dioxo-1-(phenylmethyl)-4-pyrimidiny
l)carbonyl)-L-histidy l-, hydrate | 128056-07-5 | 128056-07-5
L-Prolinamide, N-((hexahydro-2,6-dioxo-1-(phenylmethyl)-4-pyrimidinyl)carbonyl)-L-histidyl-, hydrate
|
L-Prolinamide,
N-((hexahydro-2,6-dioxo-3-(phenylmethyl)-4-pyrimidiny
l)carbonyl)-L-histidy l-, (S)-, hydrate | 128056-16-6 | 128056-16-6
L-Prolinamide, N-((hexahydro-2,6-dioxo-3-(phenylmethyl)-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate
|
L-Prolinamide,
N-((hexahydro-2,6-dioxo-1-(2-propenyl)-4-pyrimidinyl)
carbonyl)-L-histidyl-, (S)-, hydrate | 128083-58-9 | 128083-58-9
L-Prolinamide, N-((hexahydro-2,6-dioxo-1-(2-propenyl)-4-pyrimidinyl)carbonyl)-L-histidyl-, (S)-, hydrate
|
|
|